OCTREOTIDE (OCTREOTIDE ACETATE) — all Canadian products
38 DINs
21 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is OCTREOTIDE (OCTREOTIDE ACETATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02509768 | OCTREOTIDE ACETATE INJECTION | GENERIC MEDICAL PARTNERS INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Approved | |
| 02509741 | OCTREOTIDE ACETATE INJECTION | GENERIC MEDICAL PARTNERS INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Approved | |
| 02509776 | OCTREOTIDE ACETATE INJECTION | GENERIC MEDICAL PARTNERS INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Approved | |
| 02248639 | OCTREOTIDE ACETATE OMEGA | OMEGA LABORATORIES LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Marketed | |
| 02248641 | OCTREOTIDE ACETATE OMEGA | OMEGA LABORATORIES LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Marketed | |
| 02248640 | OCTREOTIDE ACETATE OMEGA | OMEGA LABORATORIES LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Marketed | |
| 02248642 | OCTREOTIDE ACETATE OMEGA | OMEGA LABORATORIES LIMITED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Marketed | |
| 02567792 | OCTREOTIDE DEPOT | STERIMAX INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG | Marketed | |
| 02567776 | OCTREOTIDE DEPOT | STERIMAX INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 10 MG | Marketed | |
| 02567784 | OCTREOTIDE DEPOT | STERIMAX INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 20 MG | Marketed | |
| 02535890 | OCTREOTIDE INJECTION | MONT-PHARMA INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Approved | |
| 02560291 | OCTREOTIDE INJECTION | STERIMAX INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Marketed | |
| 02560283 | OCTREOTIDE INJECTION | STERIMAX INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Marketed | |
| 02560240 | OCTREOTIDE INJECTION | STERIMAX INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Marketed | |
| 02535920 | OCTREOTIDE INJECTION | MONT-PHARMA INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Approved | |
| 02535912 | OCTREOTIDE INJECTION | MONT-PHARMA INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Approved | |
| 02535904 | OCTREOTIDE INJECTION | MONT-PHARMA INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Approved | |
| 00839191 | SANDOSTATIN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Marketed | |
| 02239325 | SANDOSTATIN LAR | NOVARTIS PHARMACEUTICALS CANADA INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG | Marketed | |
| 02239323 | SANDOSTATIN LAR | NOVARTIS PHARMACEUTICALS CANADA INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 10 MG | Marketed | |
| 02239324 | SANDOSTATIN LAR | NOVARTIS PHARMACEUTICALS CANADA INC | Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 20 MG | Marketed | |
| 02413191 | OCPHYL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Cancelled Post Market | |
| 02413205 | OCPHYL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Cancelled Post Market | |
| 02413213 | OCPHYL | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Cancelled Post Market | |
| 02263173 | OCTREOTIDE ACETATE INJECTION - 100MCG/ML | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Cancelled Pre Market | |
| 02263181 | OCTREOTIDE ACETATE INJECTION - 200MCG/ML | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Cancelled Pre Market | |
| 02263203 | OCTREOTIDE ACETATE INJECTION - 500MCG/ML | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Cancelled Pre Market | |
| 02263165 | OCTREOTIDE ACETATE INJECTION - 50MCG/ML | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Cancelled Pre Market | |
| 02503786 | OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Powder For Suspension (Sustained-Release; Kit | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 30 MG | Cancelled Post Market | |
| 02503751 | OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Kit; Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 10 MG | Cancelled Post Market | |
| 02503778 | OCTREOTIDE FOR INJECTABLE SUSPENSION | TEVA CANADA LIMITED | Kit; Powder For Suspension (Sustained-Release | Intramuscular | OCTREOTIDE (OCTREOTIDE ACETATE) 20 MG | Cancelled Post Market | |
| 02299445 | OCTREOTIDE INJECTION | TEVA CANADA LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Cancelled Post Market | |
| 02299453 | OCTREOTIDE INJECTION | TEVA CANADA LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Cancelled Post Market | |
| 02299429 | OCTREOTIDE INJECTION | TEVA CANADA LIMITED | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 50 MCG | Cancelled Post Market | |
| 02299437 | OCTREOTIDE INJECTION | TEVA CANADA LIMITED | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Cancelled Post Market | |
| 02049392 | SANDOSTATIN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Intravenous; Subcutaneous | OCTREOTIDE (OCTREOTIDE ACETATE) 200 MCG | Cancelled Post Market | |
| 00839213 | SANDOSTATIN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 500 MCG | Cancelled Post Market | |
| 00839205 | SANDOSTATIN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | Subcutaneous; Intravenous | OCTREOTIDE (OCTREOTIDE ACETATE) 100 MCG | Cancelled Post Market |
Browse other molecules: